|
Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cells
|
23 September 2013 |
|
Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin
|
23 September 2013 |
|
Efficacy of bromocriptine in the treatment of metastatic breast cancer- and prostate cancer-related hyperprolactinemia
|
20 September 2013 |
|
Somatostatin receptor-1 induces cell cycle arrest and inhibits tumor growth in pancreatic cancer
|
20 September 2013 |
|
Dephosphorylation of cancer protein by tyrosine phosphatases in response to analogs of luteinizing hormone-releasing hormone and somatostatin
|
19 September 2013 |
|
Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells
|
19 September 2013 |
|
Anti-proliferative and pro-apoptotic properties of 3-bromoacetoxy calcidiol in high-risk neuroblastoma
|
19 September 2013 |
|
Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer
|
18 September 2013 |
|
Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival
|
18 September 2013 |
|
Antitumor effects of somatostatin
|
17 September 2013 |